RESEARCH TRIANGLE PARK, NC--(Marketwire - November 12, 2008) - Pharmaceutical companies are finding that more than any other enticement for recruiting patients for a clinical study, the prospect of innovative treatment is the most appealing, according to "Streamlining Clinical Trials," a new study by pharmaceutical business intelligence leader Cutting Edge Information. The prospect of receiving a free treatment was the second most attractive reason for patients to join a clinical trial.

Pharmaceutical companies are constantly looking for new ways to stimulate growth and retention of patient prospects for clinical trials. The prospects of free and innovative treatments were by far the most effective methods for pharmaceutical companies to gather the necessary number of participants to a trial.

Other ways in which pharmaceutical companies are collecting an ample number of patients is through physician visits, shortened trials, and monetary compensation. One of the factors that companies wrestle with is the balance of appropriate incentives while maintaining the efficacy of the trial.

"It is encouraging for the pharmaceutical industry to find patients so eager to receive innovative treatment," says lead author of the report David Richardson. "Ideally, this mindset will translate into new and improved methods for treating indications."

"Streamlining Clinical Trials" ( covers resource allocation, performance measurement, continuous process improvement, patient and investigator recruitment and adaptive trial designs. Data include clinical development budgets, clinical operations team structures and staffing levels, performance measurement and management, clinical operations hurdles and process improvement tools and tactics. The report focuses on three aspects:

Patient Recruitment: Patient recruitment continues to dominate clinical timelines and budgets. The report devotes an entire chapter to this challenge, providing the latest trends and tools in recruitment.

Budgeting and Performance Assessments: Clinical project managers must set clear performance expectations and measure and manage trials. The report provides clinical spending benchmarks to assist in trial budgeting and planning.

Clinical Operations Structure and Work Flow: Clinical trial management team members must know their roles and responsibilities, and communication with vendors and investigators must be seamless. The report outlines major obstacles clinical teams face and presents real-company, proven solutions.

Contact Information: CONTACT INFORMATION: David Richardson 919-433-0216